Watch List: CommonWealth REIT, Titan International Inc, Affymax, Inc

Lakeway, TX -- (SBWIRE) -- 02/26/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

CommonWealth REIT (NYSE:CWH) shares jumped 32.81% to $21.06. The company yesterday reported fourth-quarter funds from operation or FFO available for common shareholders of $75.56 million or $0.90 per share, from $63.03 million or $0.75 per shares in the year ago quarter. Normalized funds from operations, or Normalized FFO, available for common shareholders for the quarter was $68.7 million, or $0.82 per share. Analysts expected the company to report earnings of $0.86 per share for the quarter. Net loss for the quarter was $163.9 million or $1.96 per share, as compared to net income of $1.1 million or $0.01 per share for the same quarter last year. Rental income for the quarter rose to $264.69 million from $233.53 million in the prior year quarter. Analysts had consensus revenue estimate of $263.56 million for the quarter.

How Should Investors Trade CWH After The Recent Movement? Find Out Here

Titan International Inc (NYSE:TWI) stock fell 12.18% to $21.92 after the company yesterday reported fourth-quarter net loss of $3.5 million or $0.07 per share, compared to net income of $14.5 million or $0.29 per share in the year-ago period. Adjusted net income for the fourth quarter was $4.1 million or $0.09 per share, compared to $18.7 million or $0.37 per share in the comparable quarter last year. Sales for latest fourth quarter rose to $493.64 million from $402.92 million in the prior year quarter. Analysts expected the company to earn $0.47 per share on revenue of $560.08 million for the fourth quarter.

Is TWI Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Affymax, Inc. (NASDAQ:AFFY) shares gained 3.31% to $2.50. Affymax and Takeda Pharmaceutical announced yesterday that they have decided to voluntarily recall all lots of OMONTYS Injection to the user level, as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis.

Additionally, JMP Securities lowered shares of AFFY from an outperform rating to an underperform rating in a research report released yesterday. JMP Securities currently has $2.50 price target on the stock.

Is AFFY a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.